Primer group for detecting pathogenic gene mutation of pheochromocytoma and paraganglioma and application method of primer group

A technology for pheochromocytoma and paraganglioma, which is applied in the field of primer sets for detecting pathogenic gene mutations in pheochromocytoma and paraganglioma, and can solve the problem of low throughput of pathogenic gene mutation detection

Pending Publication Date: 2020-08-07
BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, since each PCR reaction can only detect gene mutations in one exon of the above genes, the detection throughput of pathogenic gene mutations in pheochromocytoma and paraganglioma is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer group for detecting pathogenic gene mutation of pheochromocytoma and paraganglioma and application method of primer group
  • Primer group for detecting pathogenic gene mutation of pheochromocytoma and paraganglioma and application method of primer group
  • Primer group for detecting pathogenic gene mutation of pheochromocytoma and paraganglioma and application method of primer group

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0087] Design and synthesize primer sets

[0088] Step 1.1: Design specific upstream and downstream primers based on exons of pheochromocytoma and paraganglioma pathogenic mutation sites in SDHB, SDHC, SDHD, VHL, RET, TMEM127, and MAX genes.

[0089] For the design of primers, Primer Quest and Primer Premier 5.0 were used to design primers and analyze dimers and stem-loop mismatches. Primers were designed at both ends containing mutation sites, and the annealing temperatures of the 20 pairs of primers were basically consistent.

[0090] The primer set provided in this example covers the pathogenic mutation sites of pheochromocytoma and paraganglioma in SDHB, SDHC, SDHD, VHL, RET, TMEM127, and MAX genes. Since small sequence changes will lead to a significant decrease in primer amplification efficiency and poor specificity, multiple PCR primer sets were designed for different sites / exons, and after pre-experimental screening, the length and position of the product fragments wer...

Embodiment 2

[0102] Genomic DNA extraction from samples to be tested

[0103] Step 2.1: Collect oral exfoliated cells or fresh peripheral blood samples with oral swabs.

[0104] In this embodiment, the sample to be tested is a buccal swab sample or a fresh human peripheral blood sample.

[0105] Step 2.2: Use Tiangen Oral Swab Genomic DNA Extraction Kit (DP322), or, use Blood / Cell / Tissue Genomic DNA Extraction Kit (DP304) to extract genomic DNA from the sample, and use NP80-touch (Germany IMPLEN ) to determine the concentration and purity of DNA, and to preserve genomic DNA.

Embodiment 3

[0107] Prepare PCR reaction system

[0108] Step 3.1: Using the genomic DNA obtained in step 2.2 as an amplification template, and using the primer set synthesized in step 1.2, prepare a multiplex PCR reaction system.

[0109] In this example, the DNA polymerase and buffer in the KOD FX enzyme system (article number: KFX-101) of TOYOBO Co., Ltd. were used as the basic raw materials. concentration, buffer concentration, and enzyme dosage to prepare a multiplex PCR amplification system. The specific composition of this reaction system is shown in Table 4 below.

[0110] Table 4

[0111] Reagent components volume 5×PCR buffer for FX 26μl 2mM dNTPs 5μl Primer Mix (1 μM for each primer) 5μl KOD FX (1U / μl) 1μl amplified template 1μl Ultra-pure water 12μl

[0112] The primers were mixed equimolarly, and the total primer concentration was 10 micromolar; the amount of DNA template could be adjusted, and 30 ng of genomic DNA co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a primer group for detecting pathogenic gene mutation of pheochromocytoma and paraganglioma and an application method of the primer group. The primer group comprises at least one primer pair of twenty primer pairs from SEQ ID NO.1 to SEQ ID NO.40 and a corresponding sequencing primer. According to the scheme, the detection flux of pathogenic gene mutation of the pheochromocytoma and paraganglioma can be improved.

Description

technical field [0001] The invention relates to the technical field of gene detection, in particular to a primer set for detecting mutations in genes causing pheochromocytoma and paraganglioma and an application method thereof. Background technique [0002] Pheochromocytoma and paraganglioma (PPGL) are tumors that originate from the adrenal medulla or the extra-adrenal sympathetic nerve chain, respectively, and mainly synthesize and secrete large amounts of catecholamines (CA), such as norepinephrine (NE). , epinephrine (E) and dopamine (DA), causing a series of clinical syndromes such as elevated blood pressure in patients, and causing serious complications such as heart, brain, and kidney. [0003] At present, polymerase chain reaction (Polymerase Chain Reaction, Polymerase Chain Reaction, PCR) detection test to detect gene mutations. [0004] However, since each PCR reaction can only detect gene mutations of one exon of the above-mentioned genes, the detection throughpu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12Q1/6858C12N15/11
CPCC12Q1/6886C12Q1/6858C12Q2600/156C12Q2600/16
Inventor 赵方圆解娜智慧芳倪君君
Owner BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products